Votes Title Posted by Comments Unread
11

AstraZeneca versus the FTSE 100 – Which is better?

UK Value Investor 19th Jul '11
9
4

Defensive stocks - 2 buy and 1 sell

Kiran Shroff 14th Nov '18
1
16

Dividend Dogs of the FTSE 100: Six stocks for dividend hunters

Ben Hobson 7th Dec '11
23
2

Four ways to spice up the performance of your stock market portfolio

Justin Pugsley 2nd Nov '15
1
5

How to protect your portfolio with Low Volatility stocks

Ben Hobson 28th Oct '14
0
3

Are we investing in overseas markets in the right way?

Alex Naamani 19th Sep '14
0
4

GuruScreens - upgrades and downgrades - July 15th

Alex Naamani 15th Jul '14
3
2

What the market does not know

Rob Davies 6th Jun '14
0
6

Thoughts on the Magic Formula

Mark Carter 21st Dec '13
0
11

Income Investors’ Results Review (17 Feb 2013)

Miserly Investor 17th Feb '13
2
9

How to Screen For High Yield Shares

Miserly Investor 19th Jan '13
3
8

Why are we waiting? Dividend delays amongst the UK blue chips

Rob Davies 31st Oct '12
2
26

My High Yield Screen

marben100 12th Sep '12
15
2

Hybridan's Small Cap Wrap featuring Alliance Pharma, Altitude, Anglesey Mining, Avingtrans and more

Hybridan 20th Sep '12
0
1

Can a management shake-up cure AstraZeneca?

Ben Hobson 16th May '12
1
3

AstraZeneca wounded Q1 results - dividends safe?

Steven Dotsch 2nd May '12
5
2

UK dividends payout in Q1 totals £18.8bn. Will it last?

Steven Dotsch 30th Apr '12
0
13

Isaac's Thread - High Yielding Shares & other stuff

Isaac 16th May '10
334
14

Magic Formula Investing: five stocks that Joel Greenblatt would love?

Ben Hobson 17th Nov '11
0
3

Fidelity’s Michael Clark follows dividend payers

Steven Dotsch 18th Oct '11
1
2

Blue collar research best for big caps, white collar research for small caps

Rob Davies 7th Apr '11
2
14

Lies, Damned Lies and...Financial Ratios

10 Value 10 4th Mar '11
5
2

More transparency

Rob Davies 24th Feb '11
0
4

Weekly FTSE Market Report: British GDP Figures Send A Chill Through The FTSE 100

Stockopedia News 28th Jan '11
0
2

AstraZeneca Full Year Results interview with David Brennan CEO and Martin Mackay, President R&D

Cantos 27th Jan '11
0
10

Healthy return: Stockopedia speaks to Nick Ash, Managing Director of healthcare and pharma services group, Source BioScience plc

Ben Hobson 26th Aug '10
0
11

Johnson & Johnson: How well does it stack up against the likes of Glaxosmithkline, Novartis and Sanofi?

valueinvestor 25th Jul '10
0
2

Broker Watch featuring WS Atkins, Maxima Holdings, BP, BTG and Hammerson

Stockopedia News 17th Jun '10
0
1

Large Cap Bulletin featuring BP, G4S, Carillion, AstraZeneca and British Land

Stockopedia News 4th May '10
0
0

Misplaced fears?

0
0

Just gimme the drugs, doctor...

Stocktaculous 21st Dec '08
5
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.